Continuous Glucose Monitoring Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

GlobalData, January 2011, Pages: 56

“Continuous Glucose Monitoring Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016” provides key data, information and analysis on the global Continuous Glucose Monitoring (CGM) systems market. The report provides market landscape, competitive landscape and market trends information on the Continuous Glucose Monitoring (CGM) systems market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2009.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within Continuous Glucose Monitoring (CGM) systems market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Medtronic, DexCom and Abbott Laboratories.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the Continuous Glucose Monitoring (CGM) systems market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next big thing in the Continuous Glucose Monitoring (CGM) systems market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global Continuous Glucose Monitoring (CGM) systems market and the factors shaping it.

1 Table of contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 GlobalData Report Guidance

3 Disease Overview
3.1 Diabetes
3.2 Epidemiology

4 Continuous Glucose Monitoring (CGM) Systems – Overview
4.1 Cost Analysis for CGM Systems

5 Continuous Gluose Monitoring Systems – Market Characterization
5.1 Continuous Glucose Monitoring Systems Market, Global, Revenue ($m), Historic, 2005–2009
5.2 Continuous Glucose Monitoring Systems Market, Global, Revenue ($m), Forecast, 2009-2016
5.3 Continuous Glucose Monitoring Systems, Market Dynamics
5.3.1 Continuous Glucose Monitoring Systems, Market Drivers
5.3.2 Continuous Glucose Monitoring Systems, Market Restraints

6 Continuous Glucose Monitoring Systems Market, by Country, Revenue ($m), 2005-2016
6.1 Continuous Glucose Monitoring Systems Market, US, Revenue ($m), Historic, 2005–2009
6.2 Continuous Glucose Monitoring Systems Market, US, Revenue ($m), Forecast, 2009–2016
6.3 Continuous Glucose Monitoring Systems Market, Canada, Revenue ($m), Historic, 2006–2009
6.4 Continuous Glucose Monitoring Systems Market, Canada, Revenue ($m), Forecast, 2009–2016
6.5 Continuous Glucose Monitoring Systems Market, Germany, Revenue ($m), Historic, 2007–2009
6.6 Continuous Glucose Monitoring Systems Market, Germany, Revenue ($m), Forecast, 2009–2016
6.7 Continuous Glucose Monitoring Systems Market, UK, Revenue ($m), Historic, 2008–2009
6.8 Continuous Glucose Monitoring Systems Market, UK, Revenue ($m), Forecast, 2009–2016
6.9 Continuous Glucose Monitoring Systems Market, Australia, Revenue ($m), Historic, 2007–2009
6.10 Continuous Glucose Monitoring Systems Market, Australia, Revenue ($m), Forecast, 2009–2016
6.11 Continuous Glucose Monitoring Systems Market, China, Revenue ($m), Historic, 2005–2009
6.12 Continuous Glucose Monitoring Systems Market, China, Revenue ($m), Forecast, 2009–2016
6.13 Continuous Glucose Monitoring Systems Market, India, Revenue ($m), Historic, 2005–2009
6.14 Continuous Glucose Monitoring Systems Market, India, Revenue ($m), Forecast, 2009–2016

7 Continuous Glucose Monitoring Systems, Global, Key Company Shares
7.1 Continuos Glucose Monitoring Systems: Key Market Participants
7.1.1 Medtronic, Inc.
7.1.2 DexCom, Inc.
7.1.3 Abbott Diabetes Care, Inc. (Subsidiary of Abbott Laboratories)

8 Key Continuous Glucose Monitoring Systems in the Market
8.1 Abbott FreeStyle Navigator
8.1.1 Overview
8.1.2 Clinical Trial Details
8.2 Medtronic’s MiniMed Paradigm REAL-Time System
8.2.1 Overview
8.3 Medtronic’s MiniMed Guardian REAL-Time System
8.3.1 Overview
8.4 DexCom SEVEN PLUS
8.4.1 Overview

9 Continuous Glucose Monitoring Systems Market, Pipeline Assessment
9.1 Profiles of Promising Continuous Glucose Monitoring Systems Under Clinical Development
9.1.1 EyeSense Blood Glucose Measurement Device
9.1.2 HypoMon
9.1.3 MicroEye
9.1.4 NBM-200G
9.1.5 Optical Hypoglycemia Detector
9.1.6 OptiScanner 5000
9.1.7 Glucoday S
9.1.8 iGlyko system

10 Global Continuous Glucose Monitoring Systems Market: – Strategic Deals Analysis
10.1 Key Deals
10.1.1 Bayer HealthCare AG, a Subsidiary of Bayer AG, Completed the Acquisition of iSense Corporation

11 Appendix
11.1 Definitions
11.1.1 Continuous Glucose Monitoring Systems
11.2 Acronyms
11.3 Sources
11.4 Research Methodology
11.5 Secondary Research
11.6 Primary Research
11.7 Models
11.8 Forecasts
11.9 Expert Panels
11.10 GlobalData Consulting
11.11 Contact Us
11.12 Disclaimer

List of Tables
Table 1: Diabetes, Major Countries, Estimated Prevalence (Million), 2010 and 2030
Table 2: Continuous Glucose Monitoring Systems Market, Global, Revenue ($m), 2005–2009
Table 3: Continuous Glucose Monitoring Systems Market, Global, Revenue ($m), 2009–2016
Table 4: Disposable Income, Emerging Countries ($), (2002-2008)
Table 5: Continuous Glucose Monitoring Systems Market, US, Revenue ($m), 2005–2009
Table 6: Continuous Glucose Monitoring Systems Market, US, Revenue ($m), 2009–2016
Table 7: Continuous Glucose Monitoring Systems Market, Canada, Revenue ($m), 2006–2009
Table 8: Continuous Glucose Monitoring Systems Market, Canada, Revenue ($m), 2009–2016
Table 9: Continuous Glucose Monitoring Systems Market, Germany, Revenue ($m), 2007–2009
Table 10: Continuous Glucose Monitoring Systems Market, Germany, Revenue ($m), 2009–2016
Table 11: Continuous Glucose Monitoring Systems Market, UK, Revenue ($m), 2008–2009
Table 12: Continuous Glucose Monitoring Systems Market, UK, Revenue ($m), 2009–2016
Table 13: Continuous Glucose Monitoring Systems Market, Australia, Revenue ($m), 2007–2009
Table 14: Continuous Glucose Monitoring Systems Market, Australia, Revenue ($m), 2009–2016
Table 15: Continuous Glucose Monitoring Systems Market, China, Revenue ($m), 2005–2009
Table 16: Continuous Glucose Monitoring Systems Market, China, Revenue ($m), 2009–2016
Table 17: Continuous Glucose Monitoring Systems Market, India, Revenue ($m), 2005–2009
Table 18: Continuous Glucose Monitoring Systems Market, India, Revenue ($m), 2009–2016
Table 19: Continuous Glucose Monitoring Systems Market, Global, Key Company Share, Revenue ($m), 2009
Table 20: Medtronic, Inc. Marketed Products, 2010
Table 21: Medtronic, Inc. Pipeline Products, 2010
Table 22: DexCom, Marketed Products, 2010
Table 23: DexCom, Pipeline Products, 2010
Table 24: Abbott Diabetes Care, Marketed Products, 2010
Table 25: Abbott FreeStyle Navigator, Features and Benefits
Table 26: MiniMed Paradigm REAL-Time System, Features and Benefits
Table 27: MiniMed Guardian REAL-Time System, Features and Benefits
Table 28: DexCom SEVEN PLUS, Features and Benefits
Table 29: Pipeline Technology Assessment for Continuous Glucose Monitoring by Development Stage, Global
Table 30: Investigation of a Sub-Conjunctival Insert
Table 31: EyeSense Blood glucose measurement device, Product Status, 2010
Table 32: Clinical Evaluation of a Non-invasive Alarm System HypoMon for Nocturnal Hypoglycemia
Table 33: HypoMon, Product Status, 2010
Table 34: MicroEye, Product Status, 2010
Table 35: Clinical Trial to Measure Safety, Accuracy And Efficacy Of NBM-200G in Glucose Monitoring
Table 36: NBM-200G, Product Status, 2010
Table 37: Optical Hypoglycemia Detector, Product Status, 2010
Table 38: Evaluation Of A Mid-Infrared Glucose Monitor On Critically Ill Patients
Table 39: OptiScanner 5000 , Product Status, 2010
Table 40: Evaluation of Different Techniques for Subcutaneous Glucose Monitoring in Type 1 Diabetic Patients During Real-Life Glucose Excursions
Table 41: Glucoday S, Product Status, 2010
Table 42: iGlyko system, Product Status, 2010
Table 43: Continuous Glucose Monitoring Systems (Non-Invasive Systems), Pipeline Summary, 2010
Table 44: Continuous Glucose Monitoring Systems (Minimally Invasive Systems), Pipeline Summary, 2010
Table 45: Continuous Glucose Monitoring Systems, Pipeline Summary, 2010 501.2

List of Figures
Figure 1: Diabetes, Major Countries, Estimated Prevalence (Million), 2010 and 2030
Figure 2: Continuous Glucose Monitoring Systems Market, Global, Revenue ($m), 2005–2009
Figure 3: Continuous Glucose Monitoring Systems Market, Global, Revenue ($m), 2009–2016
Figure 4: Continuous Glucose Monitoring Systems Market, Drivers and Restraints
Figure 5: Continuous Glucose Monitoring Systems Market, US, Revenue ($m), 2005–2009
Figure 6: Continuous Glucose Monitoring Systems Market, US, Revenue ($m), 2009–2016
Figure 7: Continuous Glucose Monitoring Systems Market, Canada, Revenue ($m), 2006–2009
Figure 8: Continuous Glucose Monitoring Systems Market, Canada, Revenue ($m), 2009–2016
Figure 9: Continuous Glucose Monitoring Systems Market, Germany, Revenue ($m), 2007–2009
Figure 10: Continuous Glucose Monitoring Systems Market, Germany, Revenue ($m), 2009–2016
Figure 11: Continuous Glucose Monitoring Systems Market, UK, Revenue ($m), 2008–2009
Figure 12: Continuous Glucose Monitoring Systems Market, UK, Revenue ($m), 2009–2016
Figure 13: Continuous Glucose Monitoring Systems Market, Australia, Revenue ($m), 2007–2009
Figure 14: Continuous Glucose Monitoring Systems Market, Australia, Revenue ($m), 2009–2016
Figure 15: Continuous Glucose Monitoring Systems Market, China, Revenue ($m), 2005–2009
Figure 16: Continuous Glucose Monitoring Systems Market, China, Revenue ($m), 2009–2016
Figure 17: Continuous Glucose Monitoring Systems Market, India, Revenue ($m), 2005–2009
Figure 18: Continuous Glucose Monitoring Systems Market, India, Revenue ($m), 2009–2016
Figure 19: Continuous Glucose Monitoring Systems Market, Global, Key Company Share (%), 2009
Figure 20: Key Continuous Glucose Monitoring Systems in the Market
Figure 21: Pipeline Technology Assessment for Continuous Glucose Monitoring by Development Stage, Global 37

“Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016” provides key data, information and analysis on the global Continuous Glucose Monitoring (CGM) systems market. The report provides market landscape, competitive landscape and market trends information on the Continuous Glucose Monitoring (CGM) systems market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

The Global Continuous Glucose Monitoring Systems Market is Forecast to Reach $216m in 2016

Continuous Glucose Monitoring Systems Market, Global, Revenue ($m), 2009-2016

Source: The authors, Secondary Research and Interviews with Industry Experts and Key Opinion Leaders

The global Continuous Glucose Monitoring (CGM) systems market is expected to exhibit a Compound Annual Growth Rate (CAGR) of 12% from 2009-2016, to reach $216m in 2016. The increasing worldwide diabetic population is the major driver for the CGM systems market. According to the International Diabetes Federation (IDF) the global prevalence of diabetes among adults aged 20-79 years of age is 6.6% in 2010 and will increase to 7.8% by 2030. About 220 million people worldwide have diabetes and it will reach 336 million by 2030. The market opportunity is high in emerging countries as 80% of all new cases of diabetes are expected to be reported in these countries by 2025.

Also, the incidence of childhood-onset type1 diabetes in group under the age of 15 is increasing in many countries in the world. About 76,000 children aged under 15 develop type 1 diabetes annually, worldwide. The large and growing number of insulin dependent diabetes patients, specifically in the US, Western Europe, and Japan, require continuous monitoring of their glucose levels. This type 1 diabetic population serves as the major patient pool for the usage of CGM systems. The increasing demand for non-invasive systems is leading to the development of new technologies which in turn will increase patient adoption of newer systems.

The US Remains the Largest Continuous Glucose Monitoring Systems Market

The US CGM systems market is expected to reach $209.5m in 2016, growing at a CAGR of 12% from 2009 to 2016. The US remains the largest CGM market with a market share of more than 96% in 2009. The CGM systems market in the US is going to be driven by the increased penetration of well-established players. The high acceptance of CGM systems from both physicians and patients coupled with a large diabetic population and an improvement in reimbursement policies is expected to drive the US CGM systems market in the near future.

Customers who bought this item also bought

• Proteomics - Global Strategic Business Report
• Gene Amplification Technologies - Global Strategic Business Report
• Biotechnology Instrumentation - Global Strategic Business Report
• Global Biopharmaceutical Market Report & Forecast (2012-2017)
• Immunoassay Systems - Global Business Strategic Report
• Probiotics - Global Strategic Business Report
• RNA Interference (RNAi) - Global Strategic Business Report
• Stem Cell Research - Global Business Strategic Report
• Food Safety Testing - Global Strategic Business Report
• Agricultural Biotechnology - Global Strategic Business Report